Stonebridge Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Stonebridge Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 02, 2020	SELL	$166.71 - $223.91 $198,384 - $266,452	-1,190 Closed	0 $0
Q3 2019 Oct 02, 2019	SELL	$166.23 - $187.09 $64,829 - $72,965	-390 Reduced 24.68%	1,190 $201,000
Q2 2019 Jul 12, 2019	SELL	$164.61 - $190.37 $152,264 - $176,092	-925 Reduced 36.93%	1,580 $290,000
Q4 2018 Jan 25, 2019	SELL	$151.91 - $192.21 $8,658 - $10,955	-57 Reduced 2.22%	2,505 $415,000
Q3 2018 Oct 17, 2018	SELL	$167.73 - $192.74 $194,566 - $223,578	-1,160 Reduced 31.17%	2,562 $494,000

Q4 2017 Jan 29, 2018	BUY	$137.28 - $155.55 $510,956 - $578,957	3,722	3,722 $588,000

1,624

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Management Inc with notifications on news.